Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-15

Clinical Trial Update: Role of CGMS Usage in Predicting Risk for Hypoglycemia

View source ↗

Summary

A completed clinical trial evaluates whether continuous glucose monitoring usage can predict hypoglycemia risk in individuals with Type 2 diabetes mellitus. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Type 2 Diabetes Mellitus, Hypoglycemia | Status: COMPLETED